Keywords
Methazolamide, voice tremor, clinical rating scores
Abstract
We studied the safety and efficacy of methazolamide (average dose 168 mg/day) in a placebo-controlled blinded investigation in nine patients with essential voice tremor. There were no significant differences for physician or patient clinical rating scores. Digital audio tape recordings showed no difference for amplitude modulation, but frequency modulation was significantly altered by methazolamide. Side effects were common with the drug. We conclude that methazolamide has limited usefulness in the treatment of essential voice tremor.
Original Publication Citation
Busenbark, K., Ramig, L.O., Dromey, C., & Koller, W.C. (1996). Methazolamide for essential voice tremor. Neurology, 47, 1331-1332.
BYU ScholarsArchive Citation
Dromey, Christopher; Busenbark, Karen; Ramig, L; and Koller, William C., "Methazolamide for essential voice tremor" (1996). Faculty Publications. 7283.
https://scholarsarchive.byu.edu/facpub/7283
Document Type
Peer-Reviewed Article
Publication Date
1996
Publisher
American Academy of Neurology
Language
English
College
David O. McKay School of Education
Department
Communication Disorders
Copyright Status
©1996 by the American Academy of Neurology
Copyright Use Information
https://lib.byu.edu/about/copyright/